Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade



Baixar 8.81 Mb.
Pdf preview
Página511/535
Encontro30.06.2021
Tamanho8.81 Mb.
1   ...   507   508   509   510   511   512   513   514   ...   535
639


Atualização
Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados 
Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019
Arq Bras Cardiol. 2019; 113(3):449-663
521.  First International Study of Infarct Survival Collaborative Group. 
Randomised trial of intravenous atenolol among 16 027 cases of suspected 
acute myocardial infarction: ISIS-1. Lancet. 1986;;2(8498):57-66.
522.  International Collaborative Study Group. Reduction of infarct size with 
the early use of timolol in acute myocardial infarction. N Engl J Med. 
1984;310(1):9-15.
523.  Al-Reesi A, Al-Zadjali N, Perry J, Fergusson D, Al-Shamsi M, Al-Thagafi 
M, et al. Do beta-blockers reduce short-term mortality following acute 
myocardial infarction? A systematic review and meta-analysis. CJEM. 
2008;10(3):215-23.
524.  Horiuchi Y, Tanimoto S, Aoki J, Nakajima H, Hara K, Tanabe K. Effects of 
beta-blockers on left ventricular remodeling in patients with preserved 
ejection fraction after acute myocardial infarction. Int J Cardiol. 2016 Oct 
15;221:765-9.
525.  Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, 
intensive statin therapy on acute coronary syndrome: a meta-analysis of 
randomized controlled trials. Arch Intern Med. 2006;166(17):1814-21.
526.  Teshima Y, Yufu K, Akioka H, Iwao T, Anan F, Nakagawa M, et al. Early 
atorvastatin therapy improves cardiac function in patients with acute 
myocardial infarction. J Cardiol. 2009;53(1):58-64.
527.  Lenderink T, Boersma E, Gitt AK, Zeymer U, Wallentin L, Van de Werf F, 
et al. Patients using statin treatment within 24 h after admission for ST-
elevation acute coronary syndromes had lower mortality than non-users: 
a report from the first Euro Heart Survey on acute coronary syndromes. 
Eur Heart J. 2006;27(15):1799-804.
528.  Spencer FA, Fonarow GC, Frederick PD, Wright RS, Every N, Goldberg RJ, 
et al. Early withdrawal of statin therapy in patients with non-ST-segment 
elevation myocardial infarction: national registry of myocardial infarction. 
Arch Intern Med. 2004;164(19):2162-8.
529.  Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD, et al. 
Withdrawal of statins increases event rates in patients with acute coronary 
syndromes. Circulation. 2002;105(12):1446-52.
530.  Pourafkari L, Visnjevac O, Ghaffari S, Nader ND. Statin drugs mitigate 
cellular inflammatory response after ST elevation myocardial infarction, 
but do not affect in-hospital mortality. J Cardiovasc Thorac Res. 
2016;8(1):34-9.
531.  Marenzi G, Cosentino N, Cortinovis S, Milazzo V, Rubino M, Cabiati A, 
et al. Myocardial Infarct Size in Patients on Long-Term Statin Therapy 
Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation 
Myocardial Infarction. Am J Cardiol. 2015;116(12):1791-7.
532.  Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, 
et al. Statin administration before percutaneous coronary intervention: 
impact on periprocedural myocardial infarction. Eur Heart J. 
2004;25(20):1822-8.
533.  Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, 
et al. Atorvastatin pretreatment improves outcomes in patients with 
acute coronary syndromes undergoing early percutaneous coronary 
intervention: results of the ARMYDA-ACS randomized trial. J Am Coll 
Cardiol. 2007;49(12):1272-8.
534.  Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et 
al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. 
N Engl J Med. 2015;372(25):2387-97.
535.  Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial 
infarction. N Engl J Med. 2012;366(1):54-63.
536.  Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for 
fibrinolytic therapy in suspected acute myocardial infarction: collaborative 
overview of early mortality and major morbidity results from all randomised 
trials of more than 1000 patients. Lancet. 1994;343(8893):311-22.
537.  Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico 
(GISSI). Effectiveness of intravenous thrombolytic treatment in acute 
myocardial infarction. Lancet. 1986;1(8478):397-402.
538.  SIS-3 (Third International Study of Infarct Survival) Collaborative Group. 
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen 
activator vs anistreplase and of aspirin plus heparin vs aspirin alone 
among 41,299 cases of suspected acute myocardial infarction. Lancet. 
1992;339(8796):753-70.
539.  GUSTO investigators. An international randomized trial comparing four 
thrombolytic strategies for acute myocardial infarction. N Engl J Med. 
1993;329(10):673-82.
540.  Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) 
Investigators, Van De Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward 
P, et al. Single-bolus tenecteplase compared with front-loaded alteplase 
in acute myocardial infarction: the ASSENT-2 double-blind randomised 
trial. Lancet. 1999;354(9180):716-22.
541.  Avezum Jr A, Feldman A, Carvalho AC, Sousa AC, Mansur Ade P, Bozza 
AE, et al. V Guideline of the Brazilian Society of Cardiology on Acute 
Myocardial Infarction Treatment with ST Segment Elevation. Arq Bras 
Cardiol. 2015;105(2 Suppl 1):1-105.
542.  Pastore CA, Pinho JA, Pinho C, Samesima N, Pereira Filho HG, Kruse J, 
et al. III Diretrizes da Sociedade Brasileira de Cardiologia sobre analise 
e emissao de laudos eletrocardiograficos. Arq Bras Cardiol. 2016;106(4 
Suppl 1):1-23.
543.  Squire IB, Lawley W, Fletcher S, Holme E, Hillis WS, Hewitt C, et 
al. Humoral and cellular immune responses up to 7.5 years after 
administration of streptokinase for acute myocardial infarction. Eur Heart 
J. 1999;20(17):1245-52.
544.  GUSTO Angiographic Investigators. The effects of tissue plasminogen 
activator, streptokinase, or both on coronary-artery patency, ventricular 
function, and survival after acute myocardial infarction. N Engl J Med. 
1993;329(22):1615-22.
545.  Ross AM, Coyne KS, Moreyra E, Reiner JS, Greenhouse SW, Walker PL, 
et al. Extended mortality benefit of early postinfarction reperfusion. 
Global Utilization of Streptokinase and Tissue Plasminogen Activator for 
Occluded Coronary Arteries Trial. Circulation. 1998;97(16):1549-56.
546.  Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic 
treatment in acute myocardial infarction: reappraisal of the golden hour. 
Lancet. 1996;348(9030):771-5.
547.  Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. 
Comparison of primary coronary angioplasty and intravenous thrombolytic 
therapy for acute myocardial infarction: a quantitative review. JAMA. 
1997;278(23):2093-8.
548.  Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A 
comparison of immediate angioplasty with thrombolytic therapy for acute 
myocardial infarction. The Primary Angioplasty in Myocardial Infarction 
Study Group. N Engl J Med. 1993;328(10):673-9.
549.  Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann 
M, et al. Long distance transport for primary angioplasty vs immediate 
thrombolysis in acute myocardial infarction. Final results of the 
randomized national multicentre trial--PRAGUE-2. Eur Heart J. 
2003;24(1):94-104.
550.  Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen 
P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in 
acute myocardial infarction. N Engl J Med. 2003;349(8):733-42.
551.  Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, 
et al. Coronary angioplasty with or without stent implantation for acute 
myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction 
Study Group. N Engl J Med. 1999;341(26):1949-56.
552.  Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al. 
Comparison of angioplasty with stenting, with or without abciximab, in 
acute myocardial infarction. N Engl J Med. 2002;346(13):957-66.
553.  Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabate M, Valgimigli 
M, et al. Clinical outcomes with drug-eluting and bare-metal stents in 
patients with ST-segment elevation myocardial infarction: evidence 



Compartilhe com seus amigos:
1   ...   507   508   509   510   511   512   513   514   ...   535


©historiapt.info 2019
enviar mensagem

    Página principal